Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

PHASE3CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

November 4, 2014

Primary Completion Date

August 1, 2016

Study Completion Date

August 1, 2016

Conditions

HCVHepatitis C InfectionGenotype 4

Interventions

DRUG

2 DAA

ABT-450/r/ABT-267 tablets

DRUG

RBV

Ribavirin tablets